APGE

Apogee Therapeutics (APGE)

About Apogee Therapeutics (APGE)

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Details

Daily high

$64.95

Daily low

$61.75

Price at open

$64.45

52 Week High

$84.56

52 Week Low

$26.20

Market cap

4.3B

Dividend yield

0.00%

Volume

1.4M

Avg. volume

1.1M

P/E ratio

-14.41

Apogee Therapeutics News